These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 24275894)

  • 1. Mesenchymal stromal cells to prevent fibrosis in kidney transplantation.
    Reinders ME; de Fijter JW; Rabelink TJ
    Curr Opin Organ Transplant; 2014 Feb; 19(1):54-9. PubMed ID: 24275894
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical translation of multipotent mesenchymal stromal cells in transplantation.
    Leuning DG; Reinders ME; de Fijter JW; Rabelink TJ
    Semin Nephrol; 2014 Jul; 34(4):351-64. PubMed ID: 25217264
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Marrow Mesenchymal Stem Cells Effectively Reduce Histologic Changes in a Rat Model of Chronic Renal Allograft Rejection.
    Yu P; Wang Z; Liu Y; Xiao Z; Guo Y; Li M; Zhao M
    Transplant Proc; 2017 Nov; 49(9):2194-2203. PubMed ID: 29149982
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Autologous bone marrow-derived mesenchymal stem cells for interstitial fibrosis and tubular atrophy: a pilot study.
    Zhang L; Lai X; Guo Y; Ma J; Fang J; Li G; Xu L; Yin W; Chen Z
    Ren Fail; 2021 Dec; 43(1):1266-1275. PubMed ID: 34493167
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Autologous bone marrow derived mesenchymal stromal cell therapy in combination with everolimus to preserve renal structure and function in renal transplant recipients.
    Reinders ME; Bank JR; Dreyer GJ; Roelofs H; Heidt S; Roelen DL; Al Huurman V; Lindeman J; van Kooten C; Claas FH; Fibbe WE; Rabelink TJ; de Fijter JW
    J Transl Med; 2014 Dec; 12():331. PubMed ID: 25491391
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mesenchymal stromal cells in renal transplantation: opportunities and challenges.
    Casiraghi F; Perico N; Cortinovis M; Remuzzi G
    Nat Rev Nephrol; 2016 Apr; 12(4):241-53. PubMed ID: 26853275
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Autologous transplantation of mesenchymal stromal cells tends to prevent progress of interstitial fibrosis in a rhesus Macaca mulatta monkey model of chronic kidney disease.
    Moghadasali R; Hajinasrollah M; Argani H; Nassiri SM; Najarasl M; Sodeifi N; Baharvand H; Aghdami N
    Cytotherapy; 2015 Nov; 17(11):1495-505. PubMed ID: 26341479
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Autologous bone marrow-derived mesenchymal stromal cells for the treatment of allograft rejection after renal transplantation: results of a phase I study.
    Reinders ME; de Fijter JW; Roelofs H; Bajema IM; de Vries DK; Schaapherder AF; Claas FH; van Miert PP; Roelen DL; van Kooten C; Fibbe WE; Rabelink TJ
    Stem Cells Transl Med; 2013 Feb; 2(2):107-11. PubMed ID: 23349326
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Low-dose tacrolimus combined with donor-derived mesenchymal stem cells after renal transplantation: a prospective, non-randomized study.
    Pan GH; Chen Z; Xu L; Zhu JH; Xiang P; Ma JJ; Peng YW; Li GH; Chen XY; Fang JL; Guo YH; Zhang L; Liu LS
    Oncotarget; 2016 Mar; 7(11):12089-101. PubMed ID: 26933811
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The role of mesenchymal stromal cells in chronic transplant rejection after solid organ transplantation.
    Reinders ME; Rabelink TJ; de Fijter JW
    Curr Opin Organ Transplant; 2013 Feb; 18(1):44-50. PubMed ID: 23254697
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Safety of allogeneic bone marrow derived mesenchymal stromal cell therapy in renal transplant recipients: the neptune study.
    Reinders ME; Dreyer GJ; Bank JR; Roelofs H; Heidt S; Roelen DL; Zandvliet ML; Huurman VA; Fibbe WE; van Kooten C; Claas FH; Rabelink TJ; de Fijter JW
    J Transl Med; 2015 Nov; 13():344. PubMed ID: 26537851
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reparative and Regenerative Effects of Mesenchymal Stromal Cells-Promising Potential for Kidney Transplantation?
    Pool M; Leuvenink H; Moers C
    Int J Mol Sci; 2019 Sep; 20(18):. PubMed ID: 31540361
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Altered Expression of MicroRNAs Following Chronic Allograft Dysfunction with Interstitial Fibrosis and Tubular Atrophy.
    Soltaninejad E; Nicknam MH; Nafar M; Sharbafi MH; Keshavarz Shahbaz S; Barabadi M; Yekaninejad MS; Bahrami T; Ahmadpoor P; Amirzargar A
    Iran J Allergy Asthma Immunol; 2015 Dec; 14(6):615-23. PubMed ID: 26725559
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Mechanism for promoting repair of renal ischemia reperfusion injury by mesenchymal stem cells].
    Tao YH; Ye L; Wang YM; Wang Z
    Zhongguo Dang Dai Er Ke Za Zhi; 2013 Feb; 15(2):157-61. PubMed ID: 23428136
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intraparenchymal injection of bone marrow mesenchymal stem cells reduces kidney fibrosis after ischemia-reperfusion in cyclosporine-immunosuppressed rats.
    Alfarano C; Roubeix C; Chaaya R; Ceccaldi C; Calise D; Mias C; Cussac D; Bascands JL; Parini A
    Cell Transplant; 2012; 21(9):2009-19. PubMed ID: 22525800
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Safety and Efficacy Endpoints for Mesenchymal Stromal Cell Therapy in Renal Transplant Recipients.
    Bank JR; Rabelink TJ; de Fijter JW; Reinders ME
    J Immunol Res; 2015; 2015():391797. PubMed ID: 26258149
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Timing of Immunomodulation Induced by Mesenchymal Stromal Cells Determines the Outcome of the Graft in Experimental Renal Allotransplantation.
    Merino A; Ripoll E; de Ramon L; Bolaños N; Goma M; Bestard O; Lloberas N; Grinyo JM; Ambròs JT
    Cell Transplant; 2017 Jun; 26(6):1017-1030. PubMed ID: 28160460
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Not a process of simple vicariousness, the differentiation of human adipose-derived mesenchymal stem cells to renal tubular epithelial cells plays an important role in acute kidney injury repairing.
    Li K; Han Q; Yan X; Liao L; Zhao RC
    Stem Cells Dev; 2010 Aug; 19(8):1267-75. PubMed ID: 19874085
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intrarenal Delivery of Mesenchymal Stem Cells and Endothelial Progenitor Cells Attenuates Hypertensive Cardiomyopathy in Experimental Renovascular Hypertension.
    Eirin A; Zhu XY; Ebrahimi B; Krier JD; Riester SM; van Wijnen AJ; Lerman A; Lerman LO
    Cell Transplant; 2015; 24(10):2041-53. PubMed ID: 25420012
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mesenchymal Stem Cells in Kidney Repair.
    Morigi M; Rota C; Remuzzi G
    Methods Mol Biol; 2016; 1416():89-107. PubMed ID: 27236667
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.